ER stress promotes mitochondrial DNA mediated type-1 interferon response in beta-cells and interleukin-8 driven neutrophil chemotaxis

Beta-cell destruction in type 1 diabetes (T1D) results from the combined effect of inflammation and recurrent autoimmunity. Accumulating evidence suggests the engagement of cellular stress during the initial stage of the disease, preceding destruction and triggering immune cell infiltration. While t...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in endocrinology (Lausanne) Vol. 13; p. 991632
Main Authors: Vig, Saurabh, Lambooij, Joost M., Dekkers, Mette C., Otto, Frank, Carlotti, Françoise, Guigas, Bruno, Zaldumbide, Arnaud
Format: Journal Article
Language:English
Published: Frontiers Media S.A 12-09-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Beta-cell destruction in type 1 diabetes (T1D) results from the combined effect of inflammation and recurrent autoimmunity. Accumulating evidence suggests the engagement of cellular stress during the initial stage of the disease, preceding destruction and triggering immune cell infiltration. While the role of the endoplasmic reticulum (ER) in this process has been largely described, the participation of the other cellular organelles, particularly the mitochondria which are central mediator for beta-cell survival and function, remains poorly investigated. Here, we have explored the contribution of ER stress, in activating type-I interferon signaling and innate immune cell recruitment. Using human beta-cell line EndoC-βH1 exposed to thapsigargin, we demonstrate that induction of cellular stress correlates with mitochondria dysfunction and a significant accumulation of cytosolic mitochondrial DNA (mtDNA) that triggers neutrophils migration by an IL8-dependent mechanism. These results provide a novel mechanistic insight on how ER stress can cause insulitis and may ultimately facilitate the identification of potential targets to protect beta-cells against immune infiltration.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Masaya Oshima, Institut National de la Santé et de la Recherche Médicale (INSERM), France; Mridusmita Saikia, Cornell University, United States; Jaeseok Han, Soonchunhyang University, South Korea
Edited by: Latif Rachdi, INSERM U1016 Institut Cochin, France
These authors have contributed equally to this work
This article was submitted to Diabetes: Molecular Mechanisms, a section of the journal Frontiers in Endocrinology
ISSN:1664-2392
1664-2392
DOI:10.3389/fendo.2022.991632